All News

Bone Biologics Announces Signing of Option to License Revolutionary Bone Growth Factor Nell-1 from UCLA for Use in Osteoporosis

BOSTON — Bone Biologics (OTCQB: BBLG), an orthobiologic company focused on regenerative medicine, announced today the signing of an option agreement with UCLA, for an opportunity to exclusively license the use of the revolutionary bone growth factor Nell-1 in the treatment of osteoporosis. Currently, Bone Biologics is funding the development and formulation of a Nell-1-based […]

AlloSource Announces Two Innovative Bone Fiber Allografts

CENTENNIAL, Colo., June 13, 2016 /PRNewswire-USNewswire/ — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced the launch of two new innovative demineralized cortical fiber allografts, AlloFuse® Cortical Fibers and the AlloFuse® Fiber Boat, for […]

MAJOR SOUTHWEST HOSPITAL GROUP DESIGNATES LATTICE BIOLOGICS AS APPROVED VENDOR

June 9, 2016 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: BLVKF) (the “Company”) announced today that it has been selected by a major hospital group in the southwest U.S. as an approved vendor.  This decision will add six new hospitals to the list of facilities currently utilizing the Company’s high quality allograft […]

Global Bioactive Wound Care Market to Post a CAGR of Close to 14% from 2016-2020, Predicts Technavio

June 13, 2016   LONDON–(BUSINESS WIRE)–According to the latest market study released by Technavio, the global bioactive wound care market is expected to grow at a CAGR of close to 14% during the forecast period. This research report titled ‘Global Bioactive Wound Care Market 2016-2020’ provides an in-depth analysis of the market in terms of revenue […]

Titan Spine Enhances Its Endoskeleton® Warranty

June 13, 2016 MEQUON, Wis.–(BUSINESS WIRE)–Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced that it is enhancing its spinal device warranty to provide a free replacement if any of the Company’s Endoskeleton® interbody fusion devices delaminate or generate particulate debris during implantation. The amended warranty […]

Austin frets proposed Zimmer Biomet takeover of LDR Holdings

By MARK TAYLOR – June 10,2016   While the stock of Austin, Texas.-based spine device maker LDR Holdings has leaped in value by 60 percent in the wake of its proposed sale to Zimmer Biomet Holdings of Warsaw, Indiana, for around $1 billion, it must feel like déjà vu all over again in the Texas capital. […]

SI-BONE, Inc. Announces 510(k) Clearance for Updated Indication for the iFuse Implant System®

SAN JOSE, Calif., June 13, 2016 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System® (“iFuse”), a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced that the U.S. Food and Drug Administration (FDA) has cleared a 510(k) to allow […]

EOI Announces that Dr. Frank Philips has Selected the FLXfit™ 3D Expandable Cage as a Major Alternative for TLIF Fusion Cases

OR AKIVA, Israel, June 13, 2016 /PRNewswire Expanding Orthopedics Inc. (EOI), a privately held medical device company focused on developing and commercializing innovative expandable devices for spine surgery, is excited to announce that Frank M. Phillips of Midwest Orthopedics at Rush in Chicago has started to use the FLXfit™ articulated and lordotic expandable cage for […]

Why the Zimmer Biomet and LDR Deal Is a Big Win

By Chris Lange June 7, 2016   Shares of LDR Holding Corp. (NASDAQ: LDRH) skyrocketed in Tuesday’s session following the definitive agreement for Zimmer Biomet Holdings Inc. (NYSE: ZBH) to acquire the company. Both boards of directors have agreed, and Zimmer Biomet will commence a tender offer to acquire all outstanding shares of LDR for […]

Vexim Strengthens Its Executive Team with the Appointments of: Sébastien Lemoine as Vice-President International Sales and Market Development; François Cathelineau as Vice-President Operations

  June 09, 2016 TOULOUSE, France–(BUSINESS WIRE)– Regulatory News EXIM (Paris:ALVXM) (FR0011072602 – ALVXM / PEA‐PME), a medical device company specializing in the minimally invasive treatment of vertebral fractures, today announced the strengthening of its executive team with the appointments of: Sébastien Lemoine as VP International Sales and Market Development and François Cathelineau as VP […]

© 2024 MedDeviceJobs.com Powered by Careerleaf
v.4.3-68-g7ed64c2